These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36672707)

  • 1. New Nitric Oxide-Releasing Compounds as Promising Anti-Bladder Cancer Drugs.
    Varela M; López M; Ingold M; Alem D; Perini V; Perelmuter K; Bollati-Fogolín M; López GV; Hernández P
    Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furoxans and tocopherol analogs-furoxan hybrids as anticancer agents.
    Pérez F; Varela M; Canclini L; Acosta S; Martínez-López W; López GV; Hernández P
    Anticancer Drugs; 2019 Apr; 30(4):330-338. PubMed ID: 30489292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Greener Synthesis of Antiproliferative Furoxans via Multicomponent Reactions.
    Ingold M; de la Sovera V; Dapueto R; Hernández P; Porcal W; López GV
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer.
    Dominguez-Escrig JL; Kelly JD; Neal DE; King SM; Davies BR
    Clin Cancer Res; 2004 Jul; 10(14):4874-84. PubMed ID: 15269164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric Oxide Inhibits NF-κB-mediated Survival Signaling: Possible Role in Overcoming TRAIL Resistance.
    Bauer JA; Lupica JA; Didonato JA; Lindner DJ
    Anticancer Res; 2020 Dec; 40(12):6751-6763. PubMed ID: 33288568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of STAT3 and Survivin silencing on the growth of human bladder carcinoma cells.
    Zhang B; Lu Z; Hou Y; Hu J; Wang C
    Tumour Biol; 2014 Jun; 35(6):5401-7. PubMed ID: 24519067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo.
    Cui X; Shen D; Kong C; Zhang Z; Zeng Y; Lin X; Liu X
    Sci Rep; 2017 Jan; 7():40723. PubMed ID: 28139689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer cell viability inhibition and apoptosis induction by baicalein through targeting the expression of anti-apoptotic genes.
    Yang Y; Liu K; Yang L; Zhang G
    Saudi J Biol Sci; 2018 Nov; 25(7):1478-1482. PubMed ID: 30505198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel nitric oxide-releasing derivatives of triptolide as antitumor and anti-inflammatory agents: Design, synthesis, biological evaluation, and nitric oxide release studies.
    Zang Y; Lai F; Fu J; Li C; Ma J; Chen C; Liu K; Zhang T; Chen X; Zhang D
    Eur J Med Chem; 2020 Mar; 190():112079. PubMed ID: 32028140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of harmine-nitric oxide donor derivatives as potential antitumor agents.
    Li Z; Apizi Y; Zhang C; Wang Z; He H; Li X; Zhu Y; Yang J; Xiao L; Wang M
    Bioorg Med Chem Lett; 2022 Jun; 65():128698. PubMed ID: 35341920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
    Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
    Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant cancer cells.
    Ren Z; Gu X; Lu B; Chen Y; Chen G; Feng J; Lin J; Zhang Y; Peng H
    J Cell Mol Med; 2016 Jun; 20(6):1095-105. PubMed ID: 26864945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of a Nitric Oxide Donating Motif into Novel PC-PLC Inhibitors Provides Enhanced Anti-Proliferative Activity.
    Rees SWP; Rees TA; Leung E; Walker CS; Barker D; Pilkington LI
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing nitric oxide donating drugs in cancer therapy through immune modulation.
    Li CY; Anuraga G; Chang CP; Weng TY; Hsu HP; Ta HDK; Su PF; Chiu PH; Yang SJ; Chen FW; Ye PH; Wang CY; Lai MD
    J Exp Clin Cancer Res; 2023 Jan; 42(1):22. PubMed ID: 36639681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGCG Enhanced the Anti-tumor Effect of Doxorubicine in Bladder Cancer via NF-κB/MDM2/p53 Pathway.
    Luo KW; Zhu XH; Zhao T; Zhong J; Gao HC; Luo XL; Huang WR
    Front Cell Dev Biol; 2020; 8():606123. PubMed ID: 33425912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
    Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G
    Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenously formed nitric oxide modulates cell growth in bladder cancer cell lines.
    Morcos E; Jansson OT; Adolfsson J; Kratz G; Wiklund NP
    Urology; 1999 Jun; 53(6):1252-7. PubMed ID: 10367864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition after exposure to transforming growth factor-β1 in human bladder cancer cell lines.
    Lee C; Lee SH; Kim DS; Jeon YS; Lee NK; Lee SE
    Korean J Urol; 2014 Jul; 55(7):487-92. PubMed ID: 25045449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel nitric oxide-releasing derivatives of pyranocarbazole as antitumor agents: Design, synthesis, biological evaluation, and nitric oxide release studies.
    Zang Y; Huang L; Chen X; Li C; Ma J; Chen X; Zhang D; Lai F
    Eur J Med Chem; 2022 Dec; 244():114832. PubMed ID: 36270090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry.
    Bonavida B; Baritaki S
    Nitric Oxide; 2011 Jan; 24(1):1-7. PubMed ID: 20933602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.